ScoreWhy is Gland Pharma Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -5.11% of over the last 5 years
2
Flat results in Dec 24
- ROCE(HY) Lowest at 11.89 %
- NET SALES(Q) At Rs 1,384.05 cr has Fallen at -6.0 %
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 04-Apr-25 and has generated -5.04% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Below par performance in long term as well as near term
- Along with generating -21.85% returns in the last 1 year, the stock has also underperformed BSE 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Gland Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Gland Pharma
-21.85%
-0.68
32.16%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.58%
EBIT Growth (5y)
-5.11%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
34.32%
Dividend Payout Ratio
42.65%
Pledged Shares
0
Institutional Holding
39.84%
ROCE (avg)
25.07%
ROE (avg)
11.79%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
33
Price to Book Value
2.61
EV to EBIT
22.60
EV to EBITDA
15.98
EV to Capital Employed
3.25
EV to Sales
3.57
PEG Ratio
32.59
Dividend Yield
1.44%
ROCE (Latest)
14.18%
ROE (Latest)
7.87%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PBDIT(Q)
Highest at Rs 359.96 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 26.01%
PAT(Q)
Highest at Rs 204.69 cr.
EPS(Q)
Highest at Rs 12.42
-4What is not working for the Company
ROCE(HY)
Lowest at 11.89 %
NET SALES(Q)
At Rs 1,384.05 cr has Fallen at -6.0 %
Loading Valuation Snapshot...
Here's what is working for Gland Pharma
Operating Profit (PBDIT) - Quarterly
Highest at Rs 359.96 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 26.01%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit After Tax (PAT) - Quarterly
Highest at Rs 204.69 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 12.42
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Gland Pharma
Net Sales - Quarterly
Lowest at Rs 1,384.05 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 1,384.05 cr has Fallen at -6.0 %
over average Net Sales of the previous four quarters of Rs 1,472.54 CrMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
